Published in PLoS Pathog on January 29, 2010
Bach1 Represses Wnt/β-Catenin Signaling and Angiogenesis. Circ Res (2015) 2.01
The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal (2012) 1.64
The BTB and CNC homology 1 (BACH1) target genes are involved in the oxidative stress response and in control of the cell cycle. J Biol Chem (2011) 1.36
Potential pitfalls in microRNA profiling. Wiley Interdiscip Rev RNA (2012) 1.14
Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma. J Hematol Oncol (2014) 1.12
γ-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis. Curr Opin Virol (2013) 1.10
Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis. Adv Virus Res (2010) 1.09
KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways. PLoS Pathog (2013) 1.08
A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival. J Virol (2012) 1.06
Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma. Mol Cancer Ther (2013) 1.05
Cooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma. Leukemia (2011) 1.04
Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies. PLoS Pathog (2013) 1.04
Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus. Cancer Res (2010) 1.03
Genomic analysis of xCT-mediated regulatory network: Identification of novel targets against AIDS-associated lymphoma. Oncotarget (2015) 1.02
Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV. Virology (2010) 1.02
Epstein-Barr virus transcytosis through polarized oral epithelial cells. J Virol (2013) 1.01
Emerging themes from EBV and KSHV microRNA targets. Viruses (2012) 1.00
Neurotransmitter signaling in the pathophysiology of microglia. Front Cell Neurosci (2013) 0.98
Modulation of Immune System by Kaposi's Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies. Front Microbiol (2012) 0.97
Kaposi's Sarcoma-Associated Herpesvirus microRNAs. Front Microbiol (2012) 0.96
Functions of Kaposi's sarcoma-associated herpesvirus microRNAs. Biochim Biophys Acta (2011) 0.95
Are reactive oxygen species always detrimental to pathogens? Antioxid Redox Signal (2013) 0.95
HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway. Nucleic Acids Res (2014) 0.92
Looking at Kaposi's Sarcoma-Associated Herpesvirus-Host Interactions from a microRNA Viewpoint. Front Microbiol (2012) 0.90
Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage. J Clin Invest (2014) 0.89
Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection. J Virol (2012) 0.89
Latency locus complements MicroRNA 155 deficiency in vivo. J Virol (2013) 0.88
Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight. Curr Neuropharmacol (2015) 0.87
Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258. J Virol (2014) 0.87
Kaposi's sarcoma-associated herpesvirus encodes a mimic of cellular miR-23. J Virol (2013) 0.87
KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts. Int J Cell Biol (2012) 0.86
The Role of microRNAs in the Pathogenesis of Herpesvirus Infection. Viruses (2016) 0.85
Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1. J Virol (2014) 0.84
A KSHV microRNA Directly Targets G Protein-Coupled Receptor Kinase 2 to Promote the Migration and Invasion of Endothelial Cells by Inducing CXCR2 and Activating AKT Signaling. PLoS Pathog (2015) 0.84
Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication. Recent Results Cancer Res (2014) 0.84
Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy. J Clin Invest (2016) 0.82
Lipoteichoic acid (LTA) and lipopolysaccharides (LPS) from periodontal pathogenic bacteria facilitate oncogenic herpesvirus infection within primary oral cells. PLoS One (2014) 0.82
Kaposi Sarcoma Herpesvirus Induces HO-1 during De Novo Infection of Endothelial Cells via Viral miRNA-Dependent and -Independent Mechanisms. MBio (2015) 0.81
Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses. PLoS Pathog (2015) 0.81
Viral miRNA targeting of bicistronic and polycistronic transcripts. Curr Opin Virol (2014) 0.79
KSHV Genome Replication and Maintenance. Front Microbiol (2016) 0.78
HITS-CLIP and PAR-CLIP advance viral miRNA targetome analysis. Crit Rev Eukaryot Gene Expr (2014) 0.78
The SH3BGR/STAT3 Pathway Regulates Cell Migration and Angiogenesis Induced by a Gammaherpesvirus MicroRNA. PLoS Pathog (2016) 0.77
xCT, not just an amino-acid transporter: a multi-functional regulator of microbial infection and associated diseases. Front Microbiol (2015) 0.77
18F-5-fluoro-aminosuberic acid (FASu) as a potential tracer to gauge oxidative stress in breast cancer models. J Nucl Med (2016) 0.77
A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway. Oncotarget (2016) 0.76
Kaposi's Sarcoma-Associated Herpesvirus Subversion of the Anti-Inflammatory Response in Human Skin Cells Reveals Correlates of Latency and Disease Pathogenesis. J Skin Cancer (2014) 0.76
Apoptosis - an Ubiquitous T cell Immunomodulator. J Clin Cell Immunol (2011) 0.75
KSHV co-infection down-regulates HPV16 E6 and E7 from cervical cancer cells. Oncotarget (2017) 0.75
A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling. Oncogene (2017) 0.75
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (1994) 39.60
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med (1995) 21.16
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood (1995) 16.81
Requirement of bic/microRNA-155 for normal immune function. Science (2007) 16.24
Identification of microRNAs of the herpesvirus family. Nat Methods (2005) 12.98
NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol (2004) 12.93
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol (1997) 6.61
Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer (2008) 6.13
Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A (2005) 5.88
Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem (2000) 5.75
Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res (1982) 4.98
Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A (1999) 4.52
Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol (2007) 4.19
Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol (2005) 4.01
Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA (2007) 3.48
Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest (2004) 3.39
Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med (1999) 3.38
Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog (2007) 3.16
The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseases. J Cell Physiol (2008) 3.05
Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Cancer (2004) 2.98
Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol (2004) 2.89
Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet (2004) 2.47
MicroRNA miR-124 regulates neurite outgrowth during neuronal differentiation. Exp Cell Res (2008) 2.46
NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Antioxid Redox Signal (2009) 2.29
Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients. J Exp Med (1999) 2.27
HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load. N Engl J Med (2007) 2.26
The pleiotropic effects of Kaposi's sarcoma herpesvirus. J Pathol (2006) 2.19
Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J Biol Chem (2005) 2.14
Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy. J Clin Invest (1997) 2.10
Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem (2002) 2.00
Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma. Proc Natl Acad Sci U S A (2009) 1.91
DC-SIGN is a receptor for human herpesvirus 8 on dendritic cells and macrophages. J Immunol (2006) 1.78
Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med (2000) 1.64
Kaposi's sarcoma-associated herpesvirus fusion-entry receptor: cystine transporter xCT. Science (2006) 1.54
Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage. AIDS (2000) 1.50
Mono/oligoclonal pattern of Kaposi Sarcoma-associated herpesvirus (KSHV/HHV-8) episomes in primary effusion lymphoma cells. Int J Cancer (2005) 1.48
A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion. Oncogene (2007) 1.48
More on HIV-associated Kaposi's sarcoma. N Engl J Med (2008) 1.38
The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer (1998) 1.36
Histological variants of cutaneous Kaposi sarcoma. Diagn Pathol (2008) 1.36
KSHV targets multiple leukocyte lineages during long-term productive infection in NOD/SCID mice. J Clin Invest (2006) 1.29
Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells. Blood (2004) 1.23
c-Maf negatively regulates ARE-mediated detoxifying enzyme genes expression and anti-oxidant induction. Oncogene (2002) 1.22
Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci U S A (1998) 1.12
Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death. J Virol (2008) 1.05
Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma. Blood (2006) 1.03
Characterization of in vitro culture of HIV-negative Kaposi's sarcoma-derived cells. In vitro responses to alfa interferon. Arch Dermatol Res (1997) 1.03
Oxidative stress induces PKR-dependent apoptosis via IFN-gamma activation signaling in Jurkat T cells. Biochem Biophys Res Commun (2008) 1.00
Kaposi sarcoma in transplantation. Transplant Rev (Orlando) (2008) 1.00
Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. J Infect Dis (2002) 1.00
Intracellular Kaposi's sarcoma-associated herpesvirus load determines early loss of immune synapse components. J Virol (2007) 0.97
Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives. Cancer Treat Rev (2006) 0.95
Increased cystine uptake capability associated with malignant progression of Nb2 lymphoma cells. Leukemia (1997) 0.95
Nitric oxide inhibition of homocysteine-induced human endothelial cell apoptosis by down-regulation of p53-dependent Noxa expression through the formation of S-nitrosohomocysteine. J Biol Chem (2004) 0.91
Treatment of Kaposi's sarcoma after solid organ transplantation. J Clin Oncol (1997) 0.90
A cystine-cysteine shuttle mediated by xCT facilitates cellular responses to S-nitrosoalbumin. Am J Physiol Cell Physiol (2008) 0.90
In vitro studies on the lymphoma growth-inhibitory activity of sulfasalazine. Anticancer Drugs (2003) 0.87
Human herpesvirus 8/Kaposi sarcoma herpesvirus cell association during evolution of Kaposi sarcoma. J Acquir Immune Defic Syndr (2004) 0.87
MicroRNAs of Kaposi's sarcoma-associated herpes virus. Semin Cancer Biol (2008) 0.85
Regulation of pro-inflammatory responses by lipoxygenases via intracellular reactive oxygen species in vitro and in vivo. Exp Mol Med (2008) 0.85
Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi's sarcoma. Carcinogenesis (2003) 0.84
HHV-8/KSHV during the development of Kaposi's sarcoma: evaluation by polymerase chain reaction and immunohistochemistry. J Cutan Pathol (2005) 0.84
Enhanced production of nitric oxide, reactive oxygen species, and pro-inflammatory cytokines in very long chain saturated fatty acid-accumulated macrophages. Lipids Health Dis (2008) 0.83
Clinical presentations and standard therapy of AIDS-associated Kaposi's sarcoma. Hematol Oncol Clin North Am (2003) 0.81
Nitric oxide synthases in Kaposi's sarcoma are expressed predominantly by vessels and tissue macrophages. Lab Invest (1998) 0.78
Peroxynitrite mobilizes calcium ions from ryanodine-sensitive stores, a process associated with the mitochondrial accumulation of the cation and the enforced formation of species mediating cleavage of genomic DNA. Free Radic Biol Med (2006) 0.77
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64
Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol (2007) 4.19
Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol (2005) 4.01
Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog (2007) 3.16
The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol (2002) 2.32
Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication. J Biol Chem (2002) 2.21
Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. J Infect Dis (2007) 2.17
Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J Virol (2010) 1.98
Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J Leukoc Biol (2010) 1.77
Advocating for mental health patients in a system under stress. Nurs N Z (2002) 1.67
The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest. J Biol Chem (2004) 1.64
Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo. J Virol (2006) 1.63
Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. PLoS Pathog (2012) 1.53
KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Blood (2008) 1.52
KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming. Genes Dev (2010) 1.48
Role of virus-encoded microRNAs in herpesvirus biology. Trends Microbiol (2009) 1.41
Malpractice losses in obstetrics. A review of claims. N J Med (2002) 1.38
Biological characterization and next-generation genome sequencing of the unclassified Cotia virus SPAn232 (Poxviridae). J Virol (2012) 1.33
Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a. Glia (2009) 1.22
A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice. J Virol (2011) 1.22
Viral miRNAs: tools for immune evasion. Curr Opin Microbiol (2010) 1.22
Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin. J Virol (2005) 1.16
Outbreak of pulmonary infection caused by Klebsiella pneumoniae isolates harbouring blaIMP-4 and blaDHA-1 in a neonatal intensive care unit in China. J Med Microbiol (2012) 1.15
Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Biol Chem (2004) 1.14
Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma. J Hematol Oncol (2014) 1.12
γ-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis. Curr Opin Virol (2013) 1.10
The crisis of psychiatry - insights and prospects from evolutionary theory. World Psychiatry (2012) 1.08
Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin. Clin Cancer Res (2008) 1.08
High prevalence of plasmid-mediated 16S rRNA methylase gene rmtB among Escherichia coli clinical isolates from a Chinese teaching hospital. BMC Infect Dis (2010) 1.06
Emergence of blaNDM-1 among Klebsiella pneumoniae ST15 and novel ST1031 clinical isolates in China. Diagn Microbiol Infect Dis (2013) 1.05
Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma. Mol Cancer Ther (2013) 1.05
Viral-associated trichodysplasia of immunosuppression: report of a pediatric patient with response to oral valganciclovir. Arch Dermatol (2010) 1.05
Virulence gene profiling and molecular characterization of hospital-acquired Staphylococcus aureus isolates associated with bloodstream infection. Diagn Microbiol Infect Dis (2012) 1.05
Silibinin inhibits ultraviolet B radiation-induced mitogenic and survival signaling, and associated biological responses in SKH-1 mouse skin. Carcinogenesis (2005) 1.05
Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus. Cancer Res (2010) 1.03
Viral miRNAs and immune evasion. Biochim Biophys Acta (2011) 1.02
Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV. Virology (2010) 1.02
Molecular characterization and antimicrobial susceptibility of nasal Staphylococcus aureus isolates from a Chinese medical college campus. PLoS One (2011) 1.00
Pseudomembranous Aspergillus tracheobronchitis: a potential for high mortality in low-risk patients. Am J Med Sci (2013) 0.95
High prevalence of extended-spectrum beta lactamases among Salmonella enterica Typhimurium isolates from pediatric patients with diarrhea in China. PLoS One (2011) 0.95
Epstein-Barr virus and human herpesvirus 6 detection in a non-Hodgkin's diffuse large B-cell lymphoma cohort by using RNA sequencing. J Virol (2013) 0.95
Viral miRNAs. Methods Mol Biol (2011) 0.94
Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-kappaB in mouse epidermal JB6 cells. Mol Cancer Ther (2006) 0.94
Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa. J Natl Cancer Inst (2002) 0.94
Mutational analysis of the latency-associated nuclear antigen DNA-binding domain of Kaposi's sarcoma-associated herpesvirus reveals structural conservation among gammaherpesvirus origin-binding proteins. J Gen Virol (2010) 0.94
Health and aging: development of the Irish Longitudinal Study on Ageing health assessment. J Am Geriatr Soc (2013) 0.92
Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance. J Virol (2007) 0.91
Exploitation of secondary metabolites by animals: A response to homeostatic challenges. Integr Comp Biol (2009) 0.90
KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin-induced signal transduction. Int J Cancer (2011) 0.89
Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection. J Virol (2012) 0.89
Regulation of Nm23-H1 and cell invasiveness by Kaposi's sarcoma-associated herpesvirus. J Virol (2011) 0.88
Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus. J Virol (2009) 0.87
Epigenetic diversity of Kaposi's sarcoma-associated herpesvirus. Nucleic Acids Res (2013) 0.86
Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus. J Rheumatol (2007) 0.86
KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts. Int J Cell Biol (2012) 0.86
Steroids in biliary atresia: single surgeon, single centre, prospective study. J Hepatol (2013) 0.84
Differential effect of silibinin on E2F transcription factors and associated biological events in chronically UVB-exposed skin versus tumors in SKH-1 hairless mice. Mol Cancer Ther (2006) 0.84
Persistent human herpesvirus-6 infection in patients with an inherited form of the virus. J Med Virol (2013) 0.84
Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts. Cancer Lett (2011) 0.83
Staphylococcus epidermidis recovered from indwelling catheters exhibit enhanced biofilm dispersal and "self-renewal" through downregulation of agr. BMC Microbiol (2012) 0.82
Macular pigment optical density in an ageing Irish population: The Irish Longitudinal Study on Ageing. Ophthalmic Res (2010) 0.82
Continuity of care for women with breast cancer: a survey of the views and experiences of patients, carers and health care professionals. Eur J Oncol Nurs (2010) 0.81
Subclinical thyroid disorders. Lancet (2012) 0.80
Combinatorial Effect of Metformin and Lovastatin Impedes T-cell Autoimmunity and Neurodegeneration in Experimental Autoimmune Encephalomyelitis. J Clin Cell Immunol (2013) 0.79
Intrahepatic duct dilatation in type 4 choledochal malformation: pressure-related, postoperative resolution. J Pediatr Surg (2011) 0.79
AMP-activated protein kinase signaling protects oligodendrocytes that restore central nervous system functions in an experimental autoimmune encephalomyelitis model. Am J Pathol (2013) 0.78
Stability of the animal model of oleic acid-induced acute lung injury. J Bras Pneumol (2009) 0.78
Emmprin and KSHV: new partners in viral cancer pathogenesis. Cancer Lett (2013) 0.78
A systems biology approach identified different regulatory networks targeted by KSHV miR-K12-11 in B cells and endothelial cells. BMC Genomics (2014) 0.76
Renal biopsy at the onset of clinical lupus nephritis: can it yield useful information? J Rheumatol (2007) 0.75
NMDA-NR2B subtype selectivity of stereoisomeric 2-(1,2,3,4-tetrahydro-1-isoquinolyl)ethanol derivatives. Bioorg Med Chem Lett (2005) 0.75
Identification of transferable DHA-1 type AmpC β-lactamases and two mutations in quinolone resistance-determining regions of Salmonella enterica serovar Thompson. J Med Microbiol (2011) 0.75
ZATPAC: a model consortium evaluates teen programs. Zoo Biol (2009) 0.75
Office-based claims--a growing concern. N J Med (2002) 0.75